Effect of hyperhomocysteinemia on rat cardiac sarcoplasmic reticulum

Mol Cell Biochem. 2022 May;477(5):1621-1628. doi: 10.1007/s11010-022-04399-z. Epub 2022 Feb 27.

Abstract

Increased concentration of plasma homocysteine (Hcy) is an independent risk factor of cardiovascular disease, yet the mechanism by which hyperhomocysteinemia (HHcy) causes cardiac dysfunction is largely unknown. The aim of present study was to investigate the contribution of sarcoplasmic reticulum to impaired cardiac contractile function in HHCy. HHcy-induced by subcutaneous injection of Hcy (0.45 μmol/g of body weight) twice a day for a period of 2 weeks resulted in significant decrease in developed left ventricular pressure and maximum rate of ventricular relaxation. Our results show that abundances of SR Ca2+-handling proteins, Ca2+-ATPase (SERCA2), calsequestrin and histidine-rich calcium-binding protein are significantly reduced while the content of phospholamban is unchanged. Moreover, we found that increased PLN:SERCA2 ratio results in the inhibition of SERCA2 activity at low free Ca2+ concentrations. We further discovered that HHcy is not associated with increased oxidative stress in SR. Taken together, these findings suggest that disturbances in SR Ca2+ handling, caused by altered protein contents but not oxidative damage, may contribute to impaired cardiac contractility in HHcy.

Keywords: Ca2+-ATPase; Heart; Homocysteine; Protein expression; Sarcoplasmic reticulum.

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calcium-Binding Proteins / metabolism
  • Calsequestrin / metabolism
  • Heart / physiology
  • Hyperhomocysteinemia* / chemically induced
  • Myocardial Contraction
  • Myocardium / metabolism
  • Rats
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Sarcoplasmic Reticulum* / metabolism

Substances

  • Calcium-Binding Proteins
  • Calsequestrin
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Calcium